Literature DB >> 31708497

Translational science: Newly emerging science in biology and medicine - Lessons from translational research on the natriuretic peptide family and leptin.

Kazuwa Nakao1.   

Abstract

Translation is the process of turning observations in the laboratory, clinic, and community into interventions that improve the health of individuals and the public, ranging from diagnostics and therapeutics to medical procedures and behavioral changes. Translational research is defined as the effort to traverse a particular step of the translation process for a particular target or disease. Translational science is a newly emerging science, distinct from basic and clinical sciences in biology and medicine, and is a field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process. Advances in translational science will increase the efficacy and safety of translational research in all diagnostic and therapeutic areas. This report examines translational research on novel hormones, the natriuretic peptide family and leptin, which have achieved clinical applications or for which studies are still ongoing, and also emphasizes the lessons that translational science has learned from more than 30 years' experience in translational research.

Entities:  

Keywords:  BNP; CNP); animal disease model; leptin; natriuretic peptide family (ANP; rare disease; translational research; translational science

Mesh:

Substances:

Year:  2019        PMID: 31708497      PMCID: PMC6856003          DOI: 10.2183/pjab.95.037

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  184 in total

Review 1.  Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors.

Authors:  K Nakao; Y Ogawa; S Suga; H Imura
Journal:  J Hypertens       Date:  1992-10       Impact factor: 4.844

2.  Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.

Authors:  Hideyuki Kinoshita; Koichiro Kuwahara; Motohiro Nishida; Zhong Jian; Xianglu Rong; Shigeki Kiyonaka; Yoshihiro Kuwabara; Hitoshi Kurose; Ryuji Inoue; Yasuo Mori; Yuhao Li; Yasuaki Nakagawa; Satoru Usami; Masataka Fujiwara; Yuko Yamada; Takeya Minami; Kenji Ueshima; Kazuwa Nakao
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

3.  Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity.

Authors:  Kazuhiro Nakao; Koichiro Kuwahara; Toshio Nishikimi; Yasuaki Nakagawa; Hideyuki Kinoshita; Takeya Minami; Yoshihiro Kuwabara; Chinatsu Yamada; Yuko Yamada; Takeshi Tokudome; Chiaki Nagai-Okatani; Naoto Minamino; Yoko M Nakao; Shinji Yasuno; Kenji Ueshima; Masakatsu Sone; Takeshi Kimura; Kenji Kangawa; Kazuwa Nakao
Journal:  Hypertension       Date:  2017-01-03       Impact factor: 10.190

4.  Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death.

Authors:  Toshihito Fujii; Yasato Komatsu; Akihiro Yasoda; Eri Kondo; Tetsuro Yoshioka; Takuo Nambu; Naotestu Kanamoto; Masako Miura; Naohisa Tamura; Hiroshi Arai; Masashi Mukoyama; Kazuwa Nakao
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

5.  A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.

Authors:  I Kishimoto; K Rossi; D L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression.

Authors:  Koichiro Kuwahara; Hideyuki Kinoshita; Yoshihiro Kuwabara; Yasuaki Nakagawa; Satoru Usami; Takeya Minami; Yuko Yamada; Masataka Fujiwara; Kazuwa Nakao
Journal:  Mol Cell Biol       Date:  2010-07-06       Impact factor: 4.272

7.  Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Authors:  S Suga; K Nakao; K Hosoda; M Mukoyama; Y Ogawa; G Shirakami; H Arai; Y Saito; Y Kambayashi; K Inouye
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

8.  Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats.

Authors:  G Shirakami; H Itoh; S Suga; Y Komatsu; N Hama; K Mori; K Nakao
Journal:  Neurosci Lett       Date:  1993-09-03       Impact factor: 3.046

9.  Identification and expression cloning of a leptin receptor, OB-R.

Authors:  L A Tartaglia; M Dembski; X Weng; N Deng; J Culpepper; R Devos; G J Richards; L A Campfield; F T Clark; J Deeds; C Muir; S Sanker; A Moriarty; K J Moore; J S Smutko; G G Mays; E A Wool; C A Monroe; R I Tepper
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

10.  Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.

Authors:  Yusuke Shibata; Atsuko Nakatsuka; Jun Eguchi; Satoshi Miyamoto; Yukari Masuda; Motoharu Awazawa; Akinobu Takaki; Ryuichi Yoshida; Takahito Yagi; Jun Wada
Journal:  J Med Case Rep       Date:  2018-12-14
View more
  1 in total

Review 1.  Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox.

Authors:  Yaron Ilan
Journal:  J Transl Med       Date:  2021-02-04       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.